These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30188979)

  • 1. Targeting myeloperoxidase in inflammatory atherosclerosis.
    Senders ML; Mulder WJM
    Eur Heart J; 2018 Sep; 39(35):3311-3313. PubMed ID: 30188979
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque.
    Rashid I; Maghzal GJ; Chen YC; Cheng D; Talib J; Newington D; Ren M; Vajandar SK; Searle A; Maluenda A; Lindstedt EL; Jabbour A; Kettle AJ; Bongers A; Power C; Michaëlsson E; Peter K; Stocker R
    Eur Heart J; 2018 Sep; 39(35):3301-3310. PubMed ID: 30219874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
    Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial myeloperoxidase in the detection and treatment of vulnerable atherosclerotic plaque: a new dawn for an old light.
    Nadel J; Jabbour A; Stocker R
    Cardiovasc Res; 2023 Mar; 119(1):112-120. PubMed ID: 35587708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
    Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
    Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition.
    Roth Flach RJ; Su C; Bollinger E; Cortes C; Robertson AW; Opsahl AC; Coskran TM; Maresca KP; Keliher EJ; Yates PD; Kim AM; Kalgutkar AS; Buckbinder L
    PLoS One; 2019; 14(3):e0214150. PubMed ID: 30889221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion.
    Abd-Elrahman I; Kosuge H; Wises Sadan T; Ben-Nun Y; Meir K; Rubinstein C; Bogyo M; McConnell MV; Blum G
    PLoS One; 2016; 11(8):e0160522. PubMed ID: 27532109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques.
    Ronald JA; Chen JW; Chen Y; Hamilton AM; Rodriguez E; Reynolds F; Hegele RA; Rogers KA; Querol M; Bogdanov A; Weissleder R; Rutt BK
    Circulation; 2009 Aug; 120(7):592-9. PubMed ID: 19652086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Molecular Imaging of Mouse Atherosclerosis.
    McAteer MA; Choudhury RP
    Methods Mol Biol; 2015; 1339():61-83. PubMed ID: 26445781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
    Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
    Mol Imaging; 2014; 13():. PubMed ID: 24757762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
    Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
    Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.
    Liu C; Desikan R; Ying Z; Gushchina L; Kampfrath T; Deiuliis J; Wang A; Xu X; Zhong J; Rao X; Sun Q; Maiseyeu A; Parthasarathy S; Rajagopalan S
    PLoS One; 2012; 7(12):e50767. PubMed ID: 23251382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix stiffness regulates macrophage polarization in atherosclerosis.
    Wang Y; Shi R; Zhai R; Yang S; Peng T; Zheng F; Shen Y; Li M; Li L
    Pharmacol Res; 2022 May; 179():106236. PubMed ID: 35483516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE
    Thompson D; Morrice N; Grant L; Le Sommer S; Ziegler K; Whitfield P; Mody N; Wilson HM; Delibegović M
    Mol Metab; 2017 Aug; 6(8):845-853. PubMed ID: 28752048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
    Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
    J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting activated macrophages to identify the vulnerable atherosclerotic plaque.
    Johnson LL
    J Nucl Cardiol; 2017 Jun; 24(3):872-875. PubMed ID: 27251145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.